Both in Pharmaceuticals
Bicara Therapeutics vs Apnimed
Over the past year BCAX returned −61.6% and APMD returned −43.1%; their daily moves had a correlation of 0.16.
BCAX −61.6% APMD −43.1%Growth of $1, one year, split-adjusted
| Metric | BCAX | APMD |
|---|---|---|
| Price | $8.96 | $15.06 |
| Market cap | $592.9M | $627.0M |
| Today | +12.99% | −2.21% |
| 1 month | −48.2% | −30.8% |
| 6 months | −61.3% | — |
| Year to date | −46.8% | — |
| 1 year | −44.9% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $497.3M | — |
| Dividend yield | — | — |
| Volatility (60d) | 134.8% | — |
| Short % of float | 23.9% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).